November 22, 2016 /

NS Pharma’s Exon 53 Skipping Program (November 2016)

NS Pharma’s Exon 53 Skipping Program (November 2016)

On November 16, 2016, Parent Project Muscular Dystrophy and NS Pharma (US subsidiary of Nippon Shinyaku, Co.,Ltd) hosted a webinar to discuss NS Pharma’s Exon 53 Skipping Program. Dr. Clemens and Lauren Morgenroth reviewed data from the Phase I study conducted in Japan and presented the study design for the trial that is opening in the US later this month.


Join Our Mailing List